Pioglitazone Treatment for Hyperglycemic Acute Ischemic Stroke

Summary

Study objective is to determine whether Pioglitazone (PGZ) can improve clinical outcomes in hyperglycemic acute ischemic stroke (IS). The rationale for the proposed research is to develop an acute intervention that can improve neurological recovery and decrease mortality and morbidity in high-risk diabetic stroke patients.

Timeline

Start

2020-09-01

Primary completion

2021-04-07

Completion

2021-04-07

Drugs

Indications